Low-Dose Naltrexone Remains Unproven for Long COVID
A 2026 systematic review found low-certainty evidence that low-dose naltrexone may improve long COVID symptoms, but uncontrolled studies cannot establish efficacy or optimal dosing.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.